You just read:

Keryx Biopharmaceuticals Inc. Investigated For Securities Fraud By Block & Leviton After Keryx Halts The Distribution Of Auryxia And Withdraws Its Full-Year Financial Forecast

News provided by

Block & Leviton LLP

02 Aug, 2016, 11:22 ET